Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 2 1

Status

Completed 3Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 7CNS 7Breast 7Thoracic 5Gastrointestinal 5Dermatologic 4Tumor-Agnostic 3Genitourinary 3Sarcoma 2Head & Neck 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Melanoma 4Sarcoma 1Glioblastoma 1Brain Neoplasms 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Specimen Handling 28Whole-Body Irradiation 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Vaccines × Dermatologic × Clear all
NCT05264974 2026-05-27

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

University of Florida

Phase 1 Suspended
18 enrolled
DermatologicSarcoma

Melanoma, Sarcoma

NCT01973322 2025-01-09

ABSIDE

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Completed
34 enrolled
Dermatologic

Melanoma

NCT03092453 2024-12-24

Dendritic Cell Vaccination in Patients With Advanced Melanoma

University of Pennsylvania

Phase 1 Completed
5 enrolled 10 charts
Dermatologic

Melanoma

NCT02431572 2020-04-28

A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy

Massachusetts General Hospital

Phase NA Completed
11 enrolled 8 charts
CNSDermatologic

Brain Neoplasms, Glioblastoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡